RUXOLITINIB

RUXOLITINIB was reported 73257 times

These side effects are most commonly reported by patients taking RUXOLITINIB:

# Side effect Count
0 OFF LABEL USE 15250
1 DEATH 6480
2 FATIGUE 6265
3 ANAEMIA 3164
4 HAEMOGLOBIN DECREASED 3001
5 PRODUCT DOSE OMISSION ISSUE 2806
6 DIARRHOEA 2735
7 PLATELET COUNT DECREASED 2730
8 ASTHENIA 2586
9 DIZZINESS 2557
10 HEADACHE 2474
11 PRODUCT AVAILABILITY ISSUE 2392
12 DRUG INEFFECTIVE 2265
13 NAUSEA 2211
14 PNEUMONIA 2204
15 WEIGHT INCREASED 2023
16 DYSPNOEA 2011
17 PAIN 1904
18 PRURITUS 1872
19 SPLENOMEGALY 1802
20 MALAISE 1626
21 PYREXIA 1577
22 PLATELET COUNT INCREASED 1562
23 FALL 1548
24 CONTUSION 1531
25 THROMBOCYTOPENIA 1392
26 PRODUCT DOSE OMISSION 1369
27 ARTHRALGIA 1351
28 WHITE BLOOD CELL COUNT INCREASED 1349
29 RASH 1307
30 DRUG DOSE OMISSION 1247
31 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1237
32 PAIN IN EXTREMITY 1234
33 CONSTIPATION 1173
34 WEIGHT DECREASED 1171
35 BLOOD COUNT ABNORMAL 1141
36 VOMITING 1103
37 PRODUCT USE IN UNAPPROVED INDICATION 1085
38 COUGH 1060
39 FEELING ABNORMAL 1057
40 COVID-19 1029
41 WHITE BLOOD CELL COUNT DECREASED 998
42 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 991
43 MEMORY IMPAIRMENT 982
44 ABDOMINAL PAIN 964
45 MUSCLE SPASMS 949
46 DECREASED APPETITE 946
47 MYELOFIBROSIS 944
48 URINARY TRACT INFECTION 941
49 RED BLOOD CELL COUNT DECREASED 939
50 DISEASE PROGRESSION 922
51 INFECTION 899
52 CONDITION AGGRAVATED 875
53 INSOMNIA 871
54 BACK PAIN 867
55 ABDOMINAL DISCOMFORT 849
56 ILL-DEFINED DISORDER 845
57 PERIPHERAL SWELLING 826
58 EPISTAXIS 819
59 PLATELET COUNT ABNORMAL 798
60 NASOPHARYNGITIS 789
61 INCORRECT DOSE ADMINISTERED 725
62 ABDOMINAL PAIN UPPER 713
63 ABDOMINAL DISTENSION 688
64 SEPSIS 686
65 NIGHT SWEATS 675
66 BONE PAIN 673
67 SOMNOLENCE 655
68 INTENTIONAL PRODUCT USE ISSUE 640
69 HERPES ZOSTER 639
70 HYPERTENSION 608
71 GAIT DISTURBANCE 603
72 ANXIETY 601
73 INFLUENZA 601
74 DECREASED ACTIVITY 593
75 HAEMORRHAGE 587
76 ALOPECIA 557
77 MYALGIA 550
78 DEPRESSION 541
79 ILLNESS 540
80 GRAFT VERSUS HOST DISEASE 539
81 NEUTROPENIA 531
82 HAEMATOCRIT DECREASED 527
83 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 526
84 FULL BLOOD COUNT DECREASED 514
85 SKIN CANCER 507
86 STOMATITIS 507
87 FEBRILE NEUTROPENIA 502
88 HAEMOGLOBIN ABNORMAL 502
89 LABORATORY TEST ABNORMAL 501
90 PRODUCT DOSE OMISSION IN ERROR 499
91 THROMBOSIS 491
92 NEUROPATHY PERIPHERAL 488
93 FLATULENCE 485
94 PRODUCT USE ISSUE 481
95 DRY SKIN 476
96 THERAPEUTIC RESPONSE UNEXPECTED 473
97 DEHYDRATION 462
98 CHILLS 451
99 HYPOAESTHESIA 450
100 ACUTE KIDNEY INJURY 432
101 CHEST PAIN 428
102 WHITE BLOOD CELL COUNT ABNORMAL 421
103 HYPOTENSION 419
104 ACUTE MYELOID LEUKAEMIA 416
105 GENERAL PHYSICAL HEALTH DETERIORATION 411
106 OEDEMA PERIPHERAL 411
107 PANCYTOPENIA 409
108 DERMATITIS ATOPIC 396
109 MUSCULAR WEAKNESS 394
110 DRUG INTOLERANCE 393
111 CEREBROVASCULAR ACCIDENT 388
112 BALANCE DISORDER 386
113 CONFUSIONAL STATE 384
114 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 379
115 RESPIRATORY FAILURE 377
116 HYPERHIDROSIS 373
117 HOSPITALISATION 371
118 OROPHARYNGEAL PAIN 371
119 CYTOPENIA 367
120 PARAESTHESIA 366
121 PRODUCT DISTRIBUTION ISSUE 366
122 SINUSITIS 366
123 ATRIAL FIBRILLATION 360
124 RENAL FAILURE 355
125 VISUAL IMPAIRMENT 355
126 DYSPNOEA EXERTIONAL 349
127 BLOOD CHOLESTEROL INCREASED 347
128 HAEMATOCRIT INCREASED 345
129 GASTROINTESTINAL DISORDER 343
130 CHRONIC GRAFT VERSUS HOST DISEASE 341
131 FULL BLOOD COUNT ABNORMAL 339
132 SKIN LESION 338
133 ARTHRITIS 335
134 ERYTHEMA 335
135 GASTROINTESTINAL HAEMORRHAGE 335
136 CARDIAC DISORDER 333
137 SKIN DISCOLOURATION 329
138 RENAL IMPAIRMENT 327
139 JOINT SWELLING 326
140 SQUAMOUS CELL CARCINOMA 326
141 INCREASED TENDENCY TO BRUISE 325
142 DYSPHAGIA 323
143 PRODUCT PHYSICAL ISSUE 321
144 PULMONARY EMBOLISM 321
145 HAEMATOCRIT ABNORMAL 318
146 DYSPEPSIA 316
147 GOUT 312
148 HAEMOGLOBIN INCREASED 310
149 BRONCHITIS 305
150 BLOOD PRESSURE INCREASED 304
151 RENAL DISORDER 302
152 VISION BLURRED 302
153 BASAL CELL CARCINOMA 301
154 MULTIPLE ORGAN DYSFUNCTION SYNDROME 301
155 DRY MOUTH 300
156 INCREASED APPETITE 299
157 BLOOD CREATININE INCREASED 298
158 TREMOR 298
159 NEPHROLITHIASIS 291
160 FLUID RETENTION 290
161 HYPERSENSITIVITY 283
162 DRUG INTERACTION 282
163 CARDIAC FAILURE CONGESTIVE 280
164 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 278
165 SEPTIC SHOCK 273
166 MALIGNANT NEOPLASM PROGRESSION 271
167 LEUKAEMIA 267
168 SLEEP DISORDER 266
169 SKIN DISORDER 265
170 SKIN EXFOLIATION 264
171 ACNE 256
172 LEUKOCYTOSIS 256
173 CYTOMEGALOVIRUS INFECTION 255
174 SECOND PRIMARY MALIGNANCY 255
175 TOXICITY TO VARIOUS AGENTS 255
176 THERAPY NON-RESPONDER 252
177 CELLULITIS 248
178 MYOCARDIAL INFARCTION 247
179 DEPRESSED MOOD 246
180 ARTHROPATHY 244
181 SWELLING 242
182 POLLAKIURIA 239
183 OEDEMA 236
184 VIRAL INFECTION 233
185 ACUTE GRAFT VERSUS HOST DISEASE 232
186 CARDIAC FAILURE 232
187 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 232
188 MIGRAINE 231
189 BLOOD LACTATE DEHYDROGENASE INCREASED 230
190 PALPITATIONS 230
191 NEOPLASM MALIGNANT 229
192 SKIN ULCER 229
193 BLOOD IRON DECREASED 228
194 CYTOMEGALOVIRUS INFECTION REACTIVATION 228
195 DRUG HYPERSENSITIVITY 228
196 STAPHYLOCOCCAL INFECTION 224
197 UPPER RESPIRATORY TRACT INFECTION 223
198 DRY EYE 222
199 MOBILITY DECREASED 222
200 VERTIGO 221
201 HEPATIC ENZYME INCREASED 220
202 LOSS OF CONSCIOUSNESS 219
203 PLEURAL EFFUSION 219
204 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 218
205 BLOOD GLUCOSE INCREASED 215
206 GRAFT VERSUS HOST DISEASE IN SKIN 210
207 STRESS 208
208 TREATMENT FAILURE 208
209 BLISTER 206
210 HEART RATE INCREASED 205
211 BURNING SENSATION 203
212 BLOOD POTASSIUM INCREASED 201
213 DYSPHONIA 201
214 LUNG DISORDER 201
215 ALANINE AMINOTRANSFERASE INCREASED 199
216 GASTROOESOPHAGEAL REFLUX DISEASE 198
217 SPLEEN DISORDER 196
218 DISCOMFORT 195
219 HEPATOMEGALY 195
220 HYPERSOMNIA 195
221 CATARACT 194
222 ECZEMA 194
223 RHINORRHOEA 194
224 CYSTITIS 193
225 THERAPY INTERRUPTED 193
226 THROMBOTIC MICROANGIOPATHY 193
227 LIVER DISORDER 191
228 HAEMATOCHEZIA 188
229 HOT FLUSH 188
230 THERAPY PARTIAL RESPONDER 187
231 HAEMATOTOXICITY 186
232 AMNESIA 185
233 LIMB INJURY 182
234 SQUAMOUS CELL CARCINOMA OF SKIN 182
235 HAEMATOMA 181
236 IMPAIRED HEALING 181
237 ASPARTATE AMINOTRANSFERASE INCREASED 180
238 RASH MACULAR 177
239 FUNGAL INFECTION 176
240 HEAD INJURY 176
241 NO ADVERSE EVENT 176
242 SYNCOPE 176
243 CHEST DISCOMFORT 173
244 DISEASE RECURRENCE 172
245 MUSCULOSKELETAL PAIN 171
246 NASAL CONGESTION 171
247 BLOOD BILIRUBIN INCREASED 170
248 VITILIGO 170
249 DISTURBANCE IN ATTENTION 168
250 INFLAMMATION 168
251 NEUTROPHIL COUNT DECREASED 167
252 BLOOD DISORDER 165
253 HYPOACUSIS 165
254 TREATMENT NONCOMPLIANCE 165
255 URTICARIA 165
256 ADENOVIRUS INFECTION 164
257 BONE MARROW DISORDER 164
258 MUCOSAL INFLAMMATION 163
259 SEIZURE 163
260 PULMONARY OEDEMA 161
261 FEELING COLD 160
262 THROMBOCYTOSIS 159
263 BLOOD PRESSURE ABNORMAL 158
264 CHRONIC KIDNEY DISEASE 158
265 DIABETES MELLITUS 158
266 TINNITUS 158
267 RASH PRURITIC 157
268 DYSURIA 155
269 EATING DISORDER 154
270 FEELING HOT 153
271 HYPOXIA 153
272 NECK PAIN 153
273 HIP FRACTURE 152
274 ORAL HERPES 152
275 COLITIS 151
276 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 150
277 RED BLOOD CELL COUNT ABNORMAL 150
278 EARLY SATIETY 149
279 INFLUENZA LIKE ILLNESS 149
280 DEEP VEIN THROMBOSIS 147
281 DRUG RESISTANCE 147
282 RED BLOOD CELL COUNT INCREASED 146
283 MOUTH ULCERATION 145
284 LETHARGY 143
285 TACHYCARDIA 142
286 ACUTE RESPIRATORY FAILURE 141
287 DIVERTICULITIS 140
288 OXYGEN SATURATION DECREASED 139
289 THERAPEUTIC RESPONSE DECREASED 139
290 WOUND 139
291 LOCALISED INFECTION 138
292 MENTAL STATUS CHANGES 138
293 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 138
294 ENERGY INCREASED 137
295 ASPERGILLUS INFECTION 136
296 BACTERIAL INFECTION 136
297 PRODUCT PHYSICAL CONSISTENCY ISSUE 136
298 DYSGEUSIA 134
299 ASCITES 133
300 BACK DISORDER 133
301 BLOOD TEST ABNORMAL 133
302 LYMPHADENOPATHY 133
303 POOR QUALITY SLEEP 132
304 POLYCYTHAEMIA VERA 131
305 LIMB DISCOMFORT 130
306 PULMONARY HYPERTENSION 129
307 CLOSTRIDIUM DIFFICILE INFECTION 127
308 LEUKOPENIA 127
309 MUSCULOSKELETAL STIFFNESS 127
310 ASTHMA 126
311 BRONCHOPULMONARY ASPERGILLOSIS 126
312 IMMUNODEFICIENCY 125
313 PRODUCTIVE COUGH 125
314 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 124
315 CEREBRAL HAEMORRHAGE 123
316 EYE DISORDER 123
317 TRANSFUSION 123
318 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 122
319 BLOOD PRESSURE DECREASED 122
320 GASTROENTERITIS VIRAL 122
321 ORAL PAIN 122
322 SKIN HAEMORRHAGE 122
323 TUBERCULOSIS 122
324 BONE MARROW FAILURE 121
325 IMMUNOSUPPRESSION 121
326 TRANSIENT ISCHAEMIC ATTACK 121
327 CARDIAC ARREST 120
328 GAIT INABILITY 120
329 INSURANCE ISSUE 120
330 MYELOPROLIFERATIVE NEOPLASM 120
331 PALLOR 120
332 HAEMATURIA 119
333 INTERSTITIAL LUNG DISEASE 119
334 GASTRIC DISORDER 118
335 HAEMOPTYSIS 118
336 HERPES SIMPLEX 118
337 TOOTH DISORDER 118
338 LIVER FUNCTION TEST INCREASED 117
339 SERUM FERRITIN INCREASED 117
340 RESPIRATORY SYNCYTIAL VIRUS INFECTION 116
341 GRAFT VERSUS HOST DISEASE IN LIVER 115
342 EMOTIONAL DISORDER 114
343 BK VIRUS INFECTION 112
344 MYELOSUPPRESSION 111
345 BACTERAEMIA 110
346 CYTOMEGALOVIRUS VIRAEMIA 110
347 INJECTION SITE PAIN 110
348 BRAIN FOG 109
349 IRON OVERLOAD 109
350 OSTEONECROSIS 109
351 BLOOD URIC ACID INCREASED 108
352 JOINT INJURY 108
353 RASH ERYTHEMATOUS 108
354 BLOOD UREA INCREASED 107
355 OSTEOPOROSIS 107
356 IMMUNE SYSTEM DISORDER 106
357 EAR INFECTION 105
358 INTERNAL HAEMORRHAGE 105
359 MASS 105
360 HEPATIC FUNCTION ABNORMAL 104
361 HYPONATRAEMIA 104
362 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 103
363 FAECES DISCOLOURED 102
364 RIB FRACTURE 102
365 GINGIVAL BLEEDING 101
366 APPLICATION SITE PRURITUS 100
367 BLOOD SODIUM DECREASED 100
368 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 100
369 SPEECH DISORDER 100
370 SKIN IRRITATION 99
371 ACUTE RESPIRATORY DISTRESS SYNDROME 98
372 DIZZINESS POSTURAL 98
373 HYPERKALAEMIA 98
374 RESPIRATORY TRACT INFECTION 97
375 COGNITIVE DISORDER 96
376 DEMENTIA 96
377 PRIMARY MYELOFIBROSIS 96
378 ACUTE LEUKAEMIA 95
379 FEEDING DISORDER 95
380 HEPATIC FAILURE 95
381 MEDICATION ERROR 95
382 HAEMATEMESIS 94
383 HEART RATE DECREASED 94
384 NERVOUSNESS 94
385 RECTAL HAEMORRHAGE 94
386 BLOOD ALKALINE PHOSPHATASE INCREASED 93
387 BLOOD TRIGLYCERIDES INCREASED 93
388 MYELODYSPLASTIC SYNDROME 93
389 PANCREATITIS 93
390 ROAD TRAFFIC ACCIDENT 93
391 ADVERSE DRUG REACTION 92
392 CANDIDA INFECTION 92
393 COAGULOPATHY 92
394 NEUTROPHIL COUNT INCREASED 92
395 LYMPHOCYTE COUNT DECREASED 91
396 MUSCULOSKELETAL CHEST PAIN 91
397 PRODUCT PRESCRIBING ISSUE 91
398 DYSSTASIA 90
399 MALIGNANT MELANOMA 90
400 PNEUMONITIS 90
401 COVID-19 PNEUMONIA 89
402 PNEUMONIA FUNGAL 89
403 SINUS DISORDER 89
404 DISEASE COMPLICATION 88
405 RESPIRATORY DISORDER 88
406 BLAST CELL COUNT INCREASED 87
407 EXTRA DOSE ADMINISTERED 87
408 EYE PAIN 87
409 OCULAR HYPERAEMIA 87
410 RED CELL DISTRIBUTION WIDTH INCREASED 87
411 BLOOD POTASSIUM DECREASED 86
412 HEPATIC STEATOSIS 86
413 SWELLING FACE 86
414 THROAT IRRITATION 86
415 DRUG EFFECT LESS THAN EXPECTED 85
416 GENERAL PHYSICAL CONDITION ABNORMAL 85
417 LOWER RESPIRATORY TRACT INFECTION 85
418 SCIATICA 85
419 BLOOD LACTATE DEHYDROGENASE ABNORMAL 84
420 CHOLELITHIASIS 84
421 CYSTITIS HAEMORRHAGIC 84
422 POST PROCEDURAL HAEMORRHAGE 84
423 SKIN BURNING SENSATION 84
424 BLOOD IRON INCREASED 83
425 HYPOPHAGIA 83
426 PLATELET DISORDER 83
427 WITHDRAWAL SYNDROME 83
428 BLOOD GLUCOSE DECREASED 82
429 C-REACTIVE PROTEIN INCREASED 82
430 HYPOKALAEMIA 82
431 INTENTIONAL PRODUCT MISUSE 82
432 PSEUDOMONAS INFECTION 82
433 GASTRITIS 81
434 LIVER FUNCTION TEST ABNORMAL 81
435 PULMONARY MASS 81
436 BODY TEMPERATURE INCREASED 80
437 FULL BLOOD COUNT INCREASED 80
438 MENTAL DISORDER 80
439 NOCTURIA 80
440 ULCER 80
441 SCRATCH 79
442 TOOTH INFECTION 79
443 BLINDNESS 78
444 HAEMORRHAGIC DIATHESIS 78
445 HEPATITIS 78
446 HYPOGAMMAGLOBULINAEMIA 78
447 HYPOTHYROIDISM 78
448 NEURALGIA 78
449 APPLICATION SITE PAIN 77
450 BLAST CELLS PRESENT 77
451 PETECHIAE 77
452 TRANSAMINASES INCREASED 77
453 EPSTEIN-BARR VIRUS INFECTION 76
454 MUSCULOSKELETAL DISCOMFORT 76
455 OSTEOARTHRITIS 76
456 REBOUND EFFECT 76
457 IRRITABILITY 75
458 KIDNEY INFECTION 75
459 BLOOD URINE PRESENT 74
460 EAR PAIN 74
461 HEAD DISCOMFORT 74
462 LACRIMATION INCREASED 74
463 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 74
464 TERMINAL STATE 74
465 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 74
466 WHITE BLOOD CELL DISORDER 74
467 APHASIA 73
468 GAMMA-GLUTAMYLTRANSFERASE INCREASED 73
469 HEPATIC CIRRHOSIS 73
470 PERICARDIAL EFFUSION 73
471 PNEUMOCYSTIS JIROVECII PNEUMONIA 73
472 SEASONAL ALLERGY 73
473 SKIN LACERATION 73
474 HUNGER 72
475 SKIN INFECTION 72
476 EYE IRRITATION 71
477 MYOPATHY 71
478 POST PROCEDURAL COMPLICATION 71
479 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 71
480 PRODUCT DISPENSING ERROR 71
481 TOOTHACHE 71
482 APPETITE DISORDER 70
483 ENCEPHALOPATHY 70
484 GRAFT VERSUS HOST DISEASE IN LUNG 69
485 HYPERGLYCAEMIA 69
486 IRON DEFICIENCY 69
487 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 69
488 PNEUMONIA BACTERIAL 69
489 SCAB 69
490 CHRONIC MYELOID LEUKAEMIA 68
491 DISORIENTATION 68
492 FOOT FRACTURE 68
493 MELAENA 68
494 PULMONARY THROMBOSIS 68
495 VENOOCCLUSIVE LIVER DISEASE 68
496 WHEEZING 68
497 CLOSTRIDIUM DIFFICILE COLITIS 67
498 IRON DEFICIENCY ANAEMIA 67
499 MUSCLE STRAIN 67
500 PERIPHERAL COLDNESS 67
501 RHINOVIRUS INFECTION 67
502 TASTE DISORDER 67
503 AGEUSIA 66
504 ONYCHOCLASIS 66
505 PULMONARY CONGESTION 66
506 INJURY 65
507 PIGMENTATION DISORDER 65
508 SLUGGISHNESS 65
509 STAPHYLOCOCCAL BACTERAEMIA 65
510 BONE DISORDER 64
511 CRYING 64
512 GLOMERULAR FILTRATION RATE DECREASED 64
513 HEPATOTOXICITY 64
514 INTESTINAL OBSTRUCTION 64
515 PROSTATE CANCER 64
516 BRONCHIOLITIS OBLITERANS SYNDROME 63
517 EYE INFECTION 63
518 GLAUCOMA 63
519 HALLUCINATION 63
520 HERPES VIRUS INFECTION 63
521 HYPERURICAEMIA 63
522 MATERNAL EXPOSURE DURING PREGNANCY 63
523 PRODUCT STORAGE ERROR 63
524 PULMONARY HAEMORRHAGE 63
525 ADVERSE EVENT 62
526 AGITATION 62
527 SKIN FISSURES 62
528 SPINAL FRACTURE 62
529 THINKING ABNORMAL 62
530 DYSARTHRIA 61
531 ORAL DISORDER 61
532 PANCREATITIS ACUTE 61
533 ARRHYTHMIA 60
534 BLOOD PRESSURE FLUCTUATION 60
535 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 60
536 ECCHYMOSIS 60
537 ERUCTATION 60
538 INTENTIONAL DOSE OMISSION 60
539 MOVEMENT DISORDER 60
540 PROCEDURAL PAIN 60
541 STILL^S DISEASE 60
542 UPPER LIMB FRACTURE 60
543 GASTRIC ULCER 59
544 HERNIA 59
545 INTERVERTEBRAL DISC PROTRUSION 59
546 PNEUMOTHORAX 59
547 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 59
548 PRODUCT USE COMPLAINT 59
549 THERAPY CHANGE 59
550 URINARY RETENTION 59
551 BACK INJURY 58
552 BLOOD GLUCOSE ABNORMAL 58
553 DEAFNESS 58
554 EYE PRURITUS 58
555 FREQUENT BOWEL MOVEMENTS 58
556 MOUTH HAEMORRHAGE 58
557 MUSCULOSKELETAL DISORDER 58
558 PAIN OF SKIN 58
559 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 58
560 PRODUCT PACKAGING QUANTITY ISSUE 58
561 PRODUCT PRESCRIBING ERROR 58
562 ACUTE MYOCARDIAL INFARCTION 57
563 CORONARY ARTERY DISEASE 57
564 FLUSHING 57
565 ORAL CANDIDIASIS 57
566 SPLENIC INFARCTION 57
567 URINARY INCONTINENCE 57
568 BREAST CANCER 56
569 CACHEXIA 56
570 HAEMORRHOIDS 56
571 LUNG NEOPLASM MALIGNANT 56
572 RESPIRATORY DISTRESS 56
573 GASTROINTESTINAL MOTILITY DISORDER 55
574 HYPERBILIRUBINAEMIA 55
575 LYMPHOMA 55
576 SCLERODERMA 55
577 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 55
578 ACCIDENTAL EXPOSURE TO PRODUCT 54
579 ANGINA PECTORIS 54
580 DIFFUSE LARGE B-CELL LYMPHOMA 54
581 FEMUR FRACTURE 54
582 MICTURITION URGENCY 54
583 OSTEOMYELITIS 54
584 RESTLESS LEGS SYNDROME 54
585 ABNORMAL LOSS OF WEIGHT 53
586 CHROMATURIA 53
587 INTERNATIONAL NORMALISED RATIO INCREASED 53
588 MENTAL IMPAIRMENT 53
589 THYROID DISORDER 53
590 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 52
591 AQUAGENIC PRURITUS 52
592 DIARRHOEA HAEMORRHAGIC 52
593 DIPLOPIA 52
594 EXPIRED PRODUCT ADMINISTERED 52
595 GLOSSODYNIA 52
596 JAUNDICE 52
597 LIGAMENT SPRAIN 52
598 LOWER LIMB FRACTURE 52
599 PAIN IN JAW 52
600 PNEUMONIA ASPIRATION 52
601 PORTAL HYPERTENSION 52
602 RENAL FUNCTION TEST ABNORMAL 52
603 RESPIRATION ABNORMAL 52
604 STENOTROPHOMONAS INFECTION 52
605 TYPE 2 DIABETES MELLITUS 52
606 VITAMIN D DECREASED 52
607 WOUND HAEMORRHAGE 52
608 ABNORMAL FAECES 51
609 DECREASED IMMUNE RESPONSIVENESS 51
610 EPSTEIN-BARR VIRAEMIA 51
611 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51
612 POST PROCEDURAL INFECTION 51
613 SHOCK 51
614 SKIN HYPERPIGMENTATION 51
615 ABSCESS 50
616 ANKLE FRACTURE 50
617 DERMATITIS 50
618 EYE HAEMORRHAGE 50
619 LYMPHOPENIA 50
620 MEAN CELL VOLUME ABNORMAL 50
621 SURGERY 50
622 THERAPY CESSATION 50
623 TOOTH FRACTURE 50
624 CARDIO-RESPIRATORY ARREST 49
625 DYSCHEZIA 49
626 INTERLEUKIN LEVEL INCREASED 49
627 MUSCLE ATROPHY 49
628 ORAL DISCOMFORT 49
629 OSTEOPENIA 49
630 PHOTOSENSITIVITY REACTION 49
631 PRODUCT SUPPLY ISSUE 49
632 PULMONARY FIBROSIS 49
633 SNEEZING 49
634 SWOLLEN TONGUE 49
635 THIRST 49
636 WEIGHT FLUCTUATION 49
637 ANAPHYLACTIC REACTION 48
638 CARDIOVASCULAR DISORDER 48
639 CONJUNCTIVITIS 48
640 CYTOKINE RELEASE SYNDROME 48
641 HYPOALBUMINAEMIA 48
642 JOINT STIFFNESS 48
643 MACULAR DEGENERATION 48
644 MYCOBACTERIUM AVIUM COMPLEX INFECTION 48
645 NAIL DISCOLOURATION 48
646 ORGANISING PNEUMONIA 48
647 POST HERPETIC NEURALGIA 48
648 RENAL CYST 48
649 THERAPEUTIC PRODUCT EFFECT DECREASED 48
650 ACUTE MYELOID LEUKAEMIA RECURRENT 47
651 ARTHROPOD BITE 47
652 AUTOIMMUNE DISORDER 47
653 BLADDER DISORDER 47
654 BLOOD CHOLESTEROL ABNORMAL 47
655 BOWEL MOVEMENT IRREGULARITY 47
656 DISEASE PROPENSITY 47
657 FRUSTRATION TOLERANCE DECREASED 47
658 KLEBSIELLA INFECTION 47
659 MUSCLE TIGHTNESS 47
660 NEUROENDOCRINE CARCINOMA OF THE SKIN 47
661 PATHOGEN RESISTANCE 47
662 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 47
663 RASH MACULO-PAPULAR 47
664 RENAL PAIN 47
665 SUBDURAL HAEMATOMA 47
666 TEMPERATURE INTOLERANCE 47
667 BACTERIAL SEPSIS 46
668 DEVICE RELATED INFECTION 46
669 DRUG WITHDRAWAL SYNDROME 46
670 GALLBLADDER DISORDER 46
671 NERVOUS SYSTEM DISORDER 46
672 PARAINFLUENZAE VIRUS INFECTION 46
673 RED BLOOD CELL ABNORMALITY 46
674 SLEEP APNOEA SYNDROME 46
675 SPINAL DISORDER 46
676 UPPER GASTROINTESTINAL HAEMORRHAGE 46
677 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 45
678 ESCHERICHIA INFECTION 44
679 HEART RATE IRREGULAR 44
680 HEPATOSPLENOMEGALY 44
681 METABOLIC ACIDOSIS 44
682 MIDDLE INSOMNIA 44
683 NAIL DISORDER 44
684 PRESCRIBED OVERDOSE 44
685 RETCHING 44
686 VIRAL HAEMORRHAGIC CYSTITIS 44
687 ABNORMAL DREAMS 43
688 ALVEOLAR PROTEINOSIS 43
689 BLADDER CANCER 43
690 BLOOD CALCIUM DECREASED 43
691 CYST 43
692 DELIRIUM 43
693 DENTAL CARIES 43
694 DERMATITIS ACNEIFORM 43
695 EXERCISE TOLERANCE DECREASED 43
696 FLUID OVERLOAD 43
697 FRACTURE 43
698 HAEMOLYSIS 43
699 IRRITABLE BOWEL SYNDROME 43
700 LIP SWELLING 43
701 LOW DENSITY LIPOPROTEIN INCREASED 43
702 MALNUTRITION 43
703 NEOPLASM 43
704 SKIN ATROPHY 43
705 TUMOUR LYSIS SYNDROME 43
706 WOUND INFECTION 43
707 WRIST FRACTURE 43
708 CHOKING 42
709 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 42
710 FLANK PAIN 42
711 GASTROENTERITIS 42
712 GASTROINTESTINAL INFECTION 42
713 GINGIVAL PAIN 42
714 HYPERTRIGLYCERIDAEMIA 42
715 INITIAL INSOMNIA 42
716 OESOPHAGITIS 42
717 PHOTOPHOBIA 42
718 PROSTATOMEGALY 42
719 SKIN PAPILLOMA 42
720 ABDOMINAL PAIN LOWER 41
721 ANGER 41
722 APHTHOUS ULCER 41
723 APPLICATION SITE ACNE 41
724 APPLICATION SITE ERYTHEMA 41
725 COMA 41
726 CORONAVIRUS INFECTION 41
727 DISSEMINATED INTRAVASCULAR COAGULATION 41
728 EYE SWELLING 41
729 FEAR 41
730 FIBROSIS 41
731 HYPERPHAGIA 41
732 ORTHOSTATIC HYPOTENSION 41
733 PANIC ATTACK 41
734 RESPIRATORY TRACT CONGESTION 41
735 RHEUMATOID ARTHRITIS 41
736 ROSACEA 41
737 BONE MARROW TRANSPLANT 40
738 FAECES SOFT 40
739 INTESTINAL PERFORATION 40
740 LUNG INFECTION 40
741 MELANOCYTIC NAEVUS 40
742 NOCARDIOSIS 40
743 PRESYNCOPE 40
744 RASH PAPULAR 40
745 ROTATOR CUFF SYNDROME 40
746 SINUS CONGESTION 40
747 VARICES OESOPHAGEAL 40
748 APHONIA 39
749 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 39
750 ENTEROCOCCAL INFECTION 39
751 HYPERTRANSAMINASAEMIA 39
752 HYPOGLYCAEMIA 39
753 LUNG INFILTRATION 39
754 MOOD SWINGS 39
755 PNEUMATOSIS INTESTINALIS 39
756 SECRETION DISCHARGE 39
757 SMALL INTESTINAL OBSTRUCTION 39
758 TOOTH LOSS 39
759 UNEVALUABLE EVENT 39
760 VIRAEMIA 39
761 ANAL INCONTINENCE 38
762 BRADYCARDIA 38
763 GLYCOSYLATED HAEMOGLOBIN INCREASED 38
764 PSORIASIS 38
765 QUALITY OF LIFE DECREASED 38
766 SKIN MASS 38
767 THERAPEUTIC RESPONSE SHORTENED 38
768 YELLOW SKIN 38
769 ACCIDENT 37
770 BLOOD CREATININE ABNORMAL 37
771 COLD SWEAT 37
772 DISEASE RISK FACTOR 37
773 DRUG ADMINISTRATION ERROR 37
774 DRY THROAT 37
775 ELECTROCARDIOGRAM QT PROLONGED 37
776 ENTEROVIRUS INFECTION 37
777 FAECES HARD 37
778 FURUNCLE 37
779 ISCHAEMIC STROKE 37
780 PERIPHERAL VASCULAR DISORDER 37
781 PRODUCT TEMPERATURE EXCURSION ISSUE 37
782 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 37
783 PROTEINURIA 37
784 SKIN ABRASION 37
785 THERAPEUTIC PRODUCT EFFECT DELAYED 37
786 ULCER HAEMORRHAGE 37
787 UPPER-AIRWAY COUGH SYNDROME 37
788 VAGINAL HAEMORRHAGE 37
789 VENOOCCLUSIVE DISEASE 37
790 BLOOD ERYTHROPOIETIN ABNORMAL 36
791 DISCOURAGEMENT 36
792 DYSKINESIA 36
793 FLUID INTAKE REDUCED 36
794 FUNGAL SKIN INFECTION 36
795 HORDEOLUM 36
796 HYPOCALCAEMIA 36
797 INCONTINENCE 36
798 MONOCYTE COUNT INCREASED 36
799 PORTAL VEIN THROMBOSIS 36
800 VARICELLA ZOSTER VIRUS INFECTION 36
801 CARDIOMEGALY 35
802 INTERNATIONAL NORMALISED RATIO DECREASED 35
803 LACTIC ACIDOSIS 35
804 LARYNGITIS 35
805 LIVER INJURY 35
806 MEAN CELL VOLUME INCREASED 35
807 MITRAL VALVE INCOMPETENCE 35
808 MOOD ALTERED 35
809 NEUTROPHIL COUNT ABNORMAL 35
810 NIGHTMARE 35
811 ONYCHOMYCOSIS 35
812 ORAL MUCOSAL BLISTERING 35
813 PARKINSON^S DISEASE 35
814 PRECANCEROUS SKIN LESION 35
815 PRODUCT DEPOSIT 35
816 PULMONARY TUBERCULOSIS 35
817 TENDERNESS 35
818 URINARY TRACT INFECTION BACTERIAL 35
819 APATHY 34
820 BENIGN PROSTATIC HYPERPLASIA 34
821 GRAFT VERSUS HOST DISEASE IN EYE 34
822 HAIR TEXTURE ABNORMAL 34
823 HOSPICE CARE 34
824 HYPERLIPIDAEMIA 34
825 INJECTION SITE SWELLING 34
826 NERVE COMPRESSION 34
827 RETINAL HAEMORRHAGE 34
828 WEIGHT LOSS POOR 34
829 WRONG TECHNIQUE IN DRUG USAGE PROCESS 34
830 BASOPHIL COUNT INCREASED 33
831 CARDIAC MURMUR 33
832 CARDIAC VALVE DISEASE 33
833 COLITIS ULCERATIVE 33
834 COLON CANCER 33
835 ENTEROCOCCAL BACTERAEMIA 33
836 GLUCOSE TOLERANCE IMPAIRED 33
837 HAEMATOLOGICAL INFECTION 33
838 MENISCUS INJURY 33
839 METASTASES TO LIVER 33
840 MUSCLE TWITCHING 33
841 PSYCHIATRIC SYMPTOM 33
842 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33
843 SENSITIVE SKIN 33
844 ABDOMINAL TENDERNESS 32
845 ACTINIC KERATOSIS 32
846 CARDIOMYOPATHY 32
847 CHRONIC LYMPHOCYTIC LEUKAEMIA 32
848 EAR DISCOMFORT 32
849 EMOTIONAL DISTRESS 32
850 GASTRIC HAEMORRHAGE 32
851 HEPATIC ENZYME ABNORMAL 32
852 HIATUS HERNIA 32
853 OVERDOSE 32
854 SARS-COV-2 TEST POSITIVE 32
855 STEM CELL TRANSPLANT 32
856 BLOOD ALBUMIN DECREASED 31
857 BLOOD BLISTER 31
858 ESSENTIAL THROMBOCYTHAEMIA 31
859 GROIN PAIN 31
860 HAEMORRHAGE INTRACRANIAL 31
861 HAIR GROWTH ABNORMAL 31
862 MUCORMYCOSIS 31
863 NEPHROPATHY 31
864 PELVIC FRACTURE 31
865 PNEUMONIA PSEUDOMONAL 31
866 PNEUMONIA VIRAL 31
867 PROCEDURAL HAEMORRHAGE 31
868 RETINAL DETACHMENT 31
869 TOOTH ABSCESS 31
870 VITREOUS FLOATERS 31
871 DRUG-INDUCED LIVER INJURY 30
872 ESCHERICHIA URINARY TRACT INFECTION 30
873 EYE DISCHARGE 30
874 FEELING OF DESPAIR 30
875 HEPATIC PAIN 30
876 OBLITERATIVE BRONCHIOLITIS 30
877 PRODUCT CONTAINER ISSUE 30
878 PROSTATIC DISORDER 30
879 PULMONARY ARTERIAL HYPERTENSION 30
880 RENAL TUBULAR NECROSIS 30
881 SPLENECTOMY 30
882 UROSEPSIS 30
883 ACUTE LYMPHOCYTIC LEUKAEMIA 29
884 ATELECTASIS 29
885 BLOOD PRODUCT TRANSFUSION DEPENDENT 29
886 CEREBRAL INFARCTION 29
887 CHOLECYSTITIS 29
888 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29
889 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29
890 FOLLICULITIS 29
891 INJECTION SITE BRUISING 29
892 LACERATION 29
893 MYOSITIS 29
894 NEPHROPATHY TOXIC 29
895 PNEUMOCYSTIS JIROVECII INFECTION 29
896 SPLENIC RUPTURE 29
897 SUICIDAL IDEATION 29
898 TRANSPLANT FAILURE 29
899 ALANINE AMINOTRANSFERASE ABNORMAL 28
900 BLOOD IMMUNOGLOBULIN G DECREASED 28
901 BLOOD POTASSIUM ABNORMAL 28
902 BLOOD PRESSURE SYSTOLIC INCREASED 28
903 EYE CONTUSION 28
904 GASTROINTESTINAL ULCER 28
905 GENERALISED OEDEMA 28
906 HAEMATOLOGICAL MALIGNANCY 28
907 JOINT RANGE OF MOTION DECREASED 28
908 PANCREATIC DISORDER 28
909 PARANASAL SINUS DISCOMFORT 28
910 PNEUMONIA ADENOVIRAL 28
911 RESTLESSNESS 28
912 SKIN TIGHTNESS 28
913 SPINAL STENOSIS 28
914 STEROID DIABETES 28
915 STRESS FRACTURE 28
916 TENDONITIS 28
917 VARICOSE VEIN 28
918 ADRENAL INSUFFICIENCY 27
919 ASPARTATE AMINOTRANSFERASE ABNORMAL 27
920 BURSITIS 27
921 CONCUSSION 27
922 DIVERTICULUM 27
923 ESCHERICHIA BACTERAEMIA 27
924 HEPATITIS B REACTIVATION 27
925 INTERVERTEBRAL DISC DEGENERATION 27
926 MUSCLE DISORDER 27
927 OROPHARYNGEAL DISCOMFORT 27
928 PNEUMONIA CYTOMEGALOVIRAL 27
929 POLYURIA 27
930 POOR PERIPHERAL CIRCULATION 27
931 SPINAL OSTEOARTHRITIS 27
932 SPINAL PAIN 27
933 AORTIC STENOSIS 26
934 BEDRIDDEN 26
935 BLOOD CREATINE INCREASED 26
936 BLOOD IRON ABNORMAL 26
937 CEREBRAL DISORDER 26
938 CRITICAL ILLNESS 26
939 CYTOMEGALOVIRUS COLITIS 26
940 EPILEPSY 26
941 FOOD POISONING 26
942 FUSARIUM INFECTION 26
943 HYPERCHOLESTEROLAEMIA 26
944 LEUKAEMIA RECURRENT 26
945 ONYCHOMADESIS 26
946 OPTIC NEUROPATHY 26
947 PERITONITIS 26
948 PLASMA CELL MYELOMA 26
949 PRECANCEROUS CONDITION 26
950 PRODUCT ADMINISTRATION ERROR 26
951 PULMONARY ALVEOLAR HAEMORRHAGE 26
952 PULMONARY MUCORMYCOSIS 26
953 SERUM FERRITIN DECREASED 26
954 TONGUE ULCERATION 26
955 UNRESPONSIVE TO STIMULI 26
956 URINE ODOUR ABNORMAL 26
957 ACUTE HEPATIC FAILURE 25
958 ANOSMIA 25
959 AUTOIMMUNE HEPATITIS 25
960 BRAIN HERNIATION 25
961 CENTRAL NERVOUS SYSTEM LESION 25
962 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 25
963 DRUG ERUPTION 25
964 ELECTROLYTE IMBALANCE 25
965 EMBOLISM 25
966 EOSINOPHILIA 25
967 HAEMOLYTIC ANAEMIA 25
968 HAEMORRHAGE URINARY TRACT 25
969 HYPERCALCAEMIA 25
970 JC VIRUS INFECTION 25
971 LIGAMENT RUPTURE 25
972 LIP DRY 25
973 MUSCLE FATIGUE 25
974 NECROTISING RETINITIS 25
975 NODULE 25
976 OBSTRUCTIVE AIRWAYS DISORDER 25
977 PARVOVIRUS INFECTION 25
978 PHARYNGITIS STREPTOCOCCAL 25
979 SINUS HEADACHE 25
980 SUNBURN 25
981 SYNOVIAL CYST 25
982 VIRAL UPPER RESPIRATORY TRACT INFECTION 25
983 ABASIA 24
984 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 24
985 AGRANULOCYTOSIS 24
986 APPLICATION SITE IRRITATION 24
987 ASPIRATION 24
988 CARPAL TUNNEL SYNDROME 24
989 DECUBITUS ULCER 24
990 DISSEMINATED MUCORMYCOSIS 24
991 ENTEROCOLITIS 24
992 FAILURE TO THRIVE 24
993 GASTROINTESTINAL PAIN 24
994 GASTROINTESTINAL SOUNDS ABNORMAL 24
995 HEMIPARESIS 24
996 HEPATIC CYTOLYSIS 24
997 INFECTION SUSCEPTIBILITY INCREASED 24
998 LICHENOID KERATOSIS 24
999 LYMPHOCYTE COUNT INCREASED 24